1. Hainan Shuangcheng Pharmaceutical Co., Ltd. was founded in 2000, a listed company on the small and medium-sized board of the Shenzhen Stock Exchange (stock code: 002693), which specializes in the production, sales and research and development of chemically synthesized peptide drugs, and has formed a complete set of mature technology and process system for the chemical peptide drug synthesis, purification, analysis, quality assurance, and activity determination, The company has formed a complete set of mature technology and process system in chemical peptide synthesis, purification, analysis, quality assurance, activity determination, preparation process and other aspects. Our main products include Thymofaxine for Injection, Growth Inhibitor for Injection, Bivalirudin for Injection and so on.
2, Hainan Zhonghe Pharmaceutical Co., Ltd: Founded in April 1995, mainly engaged in peptide, nucleoside drugs research and development, production and sales. The main products include peptide drugs and nucleoside drugs two series. At present, the company's production of peptide drugs are mainly thymus pentapeptide, thymus Faxin, atosiban acetate, growth inhibitors, desmopressin acetate, octreotide acetate, etc.; the company launched the nucleoside class of antiviral drugs are mainly entecavir.
3, the peptide biochemical limited company: formerly known as Hangzhou in the peptide biochemical limited company, was founded in 2001, is a domestic and foreign pharmaceutical enterprises, scientific research institutions to provide peptide innovative drugs and peptide generics custom R & D and production services and at the same time engaged in in vitro diagnostic reagents research and development, production and sales of enterprises. 2015, the peptide biochemical limited company by the listed company, Guizhou XINBANG Pharmaceutical Co. Ltd (stock code: 002390), a listed company.
4, Jiangsu Nuotai Ausano Biopharmaceutical Co., Ltd: founded in 2009, is a company focusing on peptide drugs and small molecule drugs for independent research and development and customized R & D and production of a combination of biomedical enterprises, to build the whole industry chain from advanced pharmaceutical intermediates, APIs to preparations, and actively in the field of high-end customized, generic and innovative drug R & D layout, the main product The main products include liraglutide, somatostatin, alogliptin benzoate, eptifibatide, lanreotide acetate, oseltamivir phosphate, and thymofaxine.
5. Chengdu Shengnuo Bio-technology Co., Ltd. was founded in 2001, mainly engaged in the research, development and production of peptide drugs, the main preparation products include Atosiban Acetate Injection, Carbapenem Injection, Octreotide Acetate Injection, Thymofaxine Injection, Thymus Pentapeptide Injection, and Enfuvirtide Injection, etc., and the main products include Bivalirudin, Etipaterol, Liraglutide, Octreotide Acetate Bivalirudin, Eptifibatide, Liraglutide, Octreotide Acetate, Teriparatide, Glatiramer and other APIs have obtained DMF number and passed integrity audit.